Literature DB >> 9306597

Abnormal vaginal bleeding from endometrial polyps in a woman receiving tamoxifen therapy for breast cancer: report of a case.

T Fujikawa1, S Nishimura, S Matsusue, H Takeda.   

Abstract

We report herein the case of a women receiving tamoxifen therapy for breast cancer who developed vaginal bleeding, subsequently found to be caused by unusual endometrial polyps. Upon presentation, ultrasonography and magnetic resonance imaging (MRI) demonstrated a tumor within the uterus. A hysterectomy was performed, and macroscopic examination showed polyp-like lesions of the uterus. Histologically, these polyps demonstrated cystically dilated glands and stromal proliferation, and were diagnosed as endometrial polyps. Although tamoxifen has few side effects, any signs or symptoms of gynecological abnormalities should be carefully evaluated in patients on long-term tamoxifen therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306597     DOI: 10.1007/BF02384995

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.540


  15 in total

1.  Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.

Authors:  D Corley; J Rowe; M T Curtis; W M Hogan; J S Noumoff; V A Livolsi
Journal:  Obstet Gynecol       Date:  1992-01       Impact factor: 7.661

2.  Tamoxifen and the uterus and endometrium.

Authors:  P Neven; X De Muylder; Y Van Belle; G Vanderick; E De Muylder
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

3.  Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp.

Authors:  A H Ugwumadu; D Bower; P K Ho
Journal:  Br J Obstet Gynaecol       Date:  1993-04

Review 4.  The pharmacology and clinical uses of tamoxifen.

Authors:  B J Furr; V C Jordan
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

5.  Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.

Authors:  R R Love; R B Mazess; H S Barden; S Epstein; P A Newcomb; V C Jordan; P P Carbone; D L DeMets
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

6.  The effect of tamoxifen on the endometrium.

Authors:  B Uziely; A Lewin; G Brufman; D Dorembus; S Mor-Yosef
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.

Authors:  R R Love; D A Wiebe; P A Newcomb; L Cameron; H Leventhal; V C Jordan; J Feyzi; D L DeMets
Journal:  Ann Intern Med       Date:  1991-12-01       Impact factor: 25.391

8.  Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

Authors:  J N Ingle; D L Ahmann; S J Green; J H Edmonson; H F Bisel; L K Kvols; W C Nichols; E T Creagan; R G Hahn; J Rubin; S Frytak
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

Review 9.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

10.  Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.

Authors: 
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.